Tag: low-dose ct lung screening programs market report

  • Low-Dose Computed Tomography (CT) Lung Screening Programs Market Forecast Indicating Stable Growth Toward $2.77 Billion By 2030

    Low-Dose Computed Tomography (CT) Lung Screening Programs Market Forecast Indicating Stable Growth Toward $2.77 Billion By 2030

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Much Will The Market Value Of The Low-Dose Computed Tomography (CT) Lung Screening Programs Market Grow Between 2026 And 2030?

    The market size for low-dose computed tomography (CT) lung screening programs has witnessed substantial growth in recent years. This market is anticipated to expand from $1.66 billion in 2025 to $1.84 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.7%. The increase observed historically can be ascribed to the increasing occurrence of lung cancer cases, greater understanding of the importance of early cancer detection, stronger endorsements from clinical guidelines, the development of hospital-based screening infrastructure, and enhanced healthcare reimbursement assistance.

    The market for low-dose computed tomography (CT) lung screening programs is projected to experience substantial expansion over the coming years. This market is anticipated to reach a valuation of $2.78 billion by 2030, driven by a compound annual growth rate (CAGR) of 10.9%. Factors contributing to this growth during the forecast period include the increasing uptake of AI-assisted CT screening, the broadening of precision oncology initiatives, heightened investment in mobile healthcare delivery systems, greater incorporation of telehealth consultation services, and an increase in public-private collaborations in preventive healthcare. Key trends expected over this period involve the enlargement of government-funded lung cancer screening programs, more widespread use of mobile screening units in remote regions, enhanced integration of smoking cessation support alongside screening, a stronger focus on risk-stratified patient identification, and the expansion of radiology interpretation and subsequent monitoring services.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample_request?id=64006196&type=smp&name=Low-Dose%20Computed%20Tomography%20%28CT%29%20Lung%20Screening%20Programs%20Market%20Report%202026

    What Primary Drivers Are Shaping The Low-Dose Computed Tomography (CT) Lung Screening Programs Market?

    The increasing prevalence of lung cancer is projected to propel the expansion of the low-dose computed tomography (CT) lung screening programs market in the coming years. Lung cancer, a severe disease originating in lung tissue, involves the uncontrolled proliferation of abnormal cells and frequently shows no symptoms until it has advanced significantly. Its growing occurrence is predominantly linked to prolonged tobacco consumption, along with contributing factors like environmental air pollution and workplace carcinogens. These low-dose CT lung screening initiatives are vital for managing lung cancer, facilitating the early discovery of tumors in vulnerable groups, especially those who smoke long-term. A notable example is the data from February 2026, where the Australian Government reported approximately 15,108 new lung cancer diagnoses in 2025, representing 9.0% of all new cancer cases. Consequently, the escalating impact of lung cancer is a key factor driving the growth of the low-dose computed tomography (CT) lung screening programs market.

    Which Segment Categories Are Included In The Low-Dose Computed Tomography (CT) Lung Screening Programs Market Segment Analysis?

    The low-dose computed tomography (CT) lung screening programs market covered in this report is segmented –

    1) By Type: Hospital-Based, Independent Imaging Centers, Mobile Screening Units

    2) By Service: Screening Services, Diagnostic Follow-Up Services, Radiology Interpretation Services, Patient Identification And Risk Assessment Services, Program Management Services, Telehealth And Remote Consultation Services

    3) By Technology: Standard Low-Dose CT Screening, AI-Assisted/Computer-Aided Detection (CAD) Screening, Integrated Smoking Cessation And Screening Programs

    4) By Application: Early Detection, Risk Assessment, Follow-Up Monitoring

    5) By End User: Hospitals And Multi-Specialty Clinics, Standalone Diagnostic Imaging Centers, Mobile Screening Service Providers, Government And Public Health Agencies, Private Healthcare Networks And Insurance Providers, Employer And Corporate Wellness Programs, Academic And Research Institutions, Community Health Centers

    Subsegments:

    1) By Hospital-Based: Outpatient Department, Inpatient Department, Radiology Department

    2) By Independent Imaging Centers: Standalone Imaging Clinics, Diagnostic Centers, Specialized Lung Screening Centers

    3) By Mobile Screening Units: Bus-Based Screening Units, Van-Based Screening Units, Temporary Pop-Up Screening Units

    Which Trends Are Impacting The Progress Of The Low-Dose Computed Tomography (CT) Lung Screening Programs Market?

    Leading companies within the low-dose computed tomography (CT) lung screening programs market are prioritizing the development of sophisticated solutions, particularly artificial intelligence (AI)–assisted nodule detection, to improve early cancer detection, elevate diagnostic precision, and optimize patient management. AI-assisted nodule detection involves the application of machine-learning algorithms in lung screening initiatives to automatically identify, characterize, and prioritize pulmonary nodules on low-dose CT scans, thereby facilitating prompt follow-up and intervention. For instance, in December 2025, Emory Healthcare, a US-based health system, inaugurated the Emory Healthcare Lung Screening and Nodule Program, which merges low-dose CT screening with AI-enhanced imaging technology. This program supports multidisciplinary care through the incorporation of advanced diagnostic and treatment capabilities, including robot-assisted bronchoscopy, minimally invasive lung cancer surgery, and coordinated care navigation, leading to early diagnosis, tailored treatment planning, and enhanced patient outcomes across multiple metro Atlanta locations.

    Who Are The Active Companies Shaping The Low-Dose Computed Tomography (CT) Lung Screening Programs Market?

    Major companies operating in the low-dose computed tomography (CT) lung screening programs market are Hitachi Medical Systems America Inc., Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Inc., Mayo Clinic, Columbia University Herbert Irving Comprehensive Cancer Center, Duke University Health System, Emory Healthcare, Canon Medical Systems Corporation, RadNet Inc., University of Tennessee Medical Center, McLeod Health, Holy Cross Health, Lima Memorial Health System, Memorial Sloan Kettering Cancer Center, Independence Health System, Weill Cornell Medicine & NewYork-Presbyterian Mobile Unit, Optellum Ltd., 4DMedical Pty Ltd.

    Get The Full Low-Dose Computed Tomography (CT) Lung Screening Programs Market Report:

    https://www.thebusinessresearchcompany.com/report/low-dose-computed-tomography-ct-lung-screening-programs-market-report

    Which Region Holds The Highest Market Share In The Low-Dose Computed Tomography (CT) Lung Screening Programs Market?

    North America was the largest region in the low-dose computed tomography (CT) lung screening programs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the low-dose computed tomography (CT) lung screening programs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Low-Dose Computed Tomography (CT) Lung Screening Programs Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/Customise?id=64006196&name=Low-Dose%20Computed%20Tomography%20%28CT%29%20Lung%20Screening%20Programs%20Market%20Report%202026&type=smp

    Browse Through More Reports Similar to the Global Low-Dose Computed Tomography (CT) Lung Screening Programs Market 2026, By The Business Research Company

    pruritus therapeutic market report 2026

    https://www.thebusinessresearchcompany.com/report/pruritus-therapeutic-global-market-report

    genomic urine testing market report 2026

    https://www.thebusinessresearchcompany.com/report/genomic-urine-testing-global-market-report

    ocular genetic diagnostic market report 2026

    https://www.thebusinessresearchcompany.com/report/ocular-genetic-diagnostic-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model